12:27 PM EDT, 10/14/2025 (MT Newswires) -- Howard Horn, Chief Financial Officer, on October 13, 2025, sold 7,942 shares in Ultragenyx Pharmaceutical ( RARE ) for $250,252. Following the Form 4 filing with the SEC, Horn has control over a total of 98,227 common shares of the company, with 98,227 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1515673/000119312525238708/xslF345X05/ownership.xml

Price: 31.60, Change: -0.42, Percent Change: -1.31